SIX1 mutation associated with enlargement of the vestibular aqueduct in a patient with branchio-oto syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 16652090.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
: The objectives of this study were to identify SIX1 gene mutations in a patient with branchio-oto syndrome (BO) and to clarify the relationship between SIX1 mutation and enlargement of the vestibular aqueduct (EVA). : A genetic study and retrospective chart review for a patient in whom EYA1 mutation had already been excluded was conducted. We studied a Japanese patient who had autosomal-dominant mixed hearing loss, a unilateral ear pit and unilateral EVA, and who was previously diagnosed as having BO. We searched for SIX1 and SLC26A4 mutations using polymerase chain reaction and direct gene sequencing. : The patient carried a heterozygous A-->G mutation at nucleotide 386 within exon 1 of SIX1 that resulted in substitution of a cysteine for a tyrosine at codon 129 (Y129C) of the gene product. Y129C is a previously identified SIX1 mutation and was not detected in any of our 164 control chromosomes. No SLC26A4 mutations were identified. : Y129C mutation in SIX1 may cause EVA as well as BO.
Medical subject headings
- Branchio-Oto-Renal Syndrome
- Genetic Predisposition to Disease
- Homeodomain Proteins
- Mutation
- Vestibular Aqueduct